Literature DB >> 1571854

Frequency and cause of Parkinson's disease.

A H Rajput1.   

Abstract

Parkinson syndrome (PS) is a common disorder in the North American population. The annual incidence rate is 20.5/100,000 population and the mean survival after onset is approximately 12.3 years. The estimated prevalence rate is about 300/100,000 population. The incidence and prevalence rates rise with advancing age. Both the widespread use of levodopa and the improved health care in general have increased the longevity in PS. The survival in PS from the time of the first clinic visit is still significantly shorter when compared with the regional age and sex matched population. The cause of IPD may be related to some environmental factor(s)--most likely a toxin. Genetic factors are not the cause but in some families, may predispose to IPD.

Entities:  

Mesh:

Year:  1992        PMID: 1571854

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

Review 1.  Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

Authors:  Tai N Tran; Trang N N Vo; Karen Frei; Daniel D Truong
Journal:  J Neural Transm (Vienna)       Date:  2018-07-03       Impact factor: 3.575

Review 2.  The clinical spectrum of levodopa-induced motor complications.

Authors:  E Hametner; K Seppi; W Poewe
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

3.  Parkinson's disease: genetics and beyond.

Authors:  N N Inamdar; D K Arulmozhi; A Tandon; S L Bodhankar
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 4.  Management of motor and non-motor symptoms in Parkinson's disease.

Authors:  Fabienne Sprenger; Werner Poewe
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

5.  Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies.

Authors:  José M Bravo-San Pedro; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Mireia Niso-Santano; Rosa A González-Polo; José M Fuentes Rodríguez
Journal:  Parkinsons Dis       Date:  2012-08-30

Review 6.  Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results.

Authors:  E D Clarkson
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

Review 7.  Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review.

Authors:  Ramu Venkatesan; Eunhee Ji; Sun Yeou Kim
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

8.  [Frequency and clinical profile of Parkinson's disease and other Parkinsonian syndromes seen in the Department of Neurology at the Befelatanana Hospital Antananarivo].

Authors:  Nomena Finiavana Rasaholiarison; Julien Razafimahefa; Jenny Larissa Rakotomanana; Alain Djacoba Tehindrazanarivelo
Journal:  Pan Afr Med J       Date:  2019-07-18

9.  Associations between Brain Structural Damage and Core Muscle Loss in Patients with Parkinson's Disease.

Authors:  Ying-Nong Wu; Meng-Hsiang Chen; Pi-Ling Chiang; Cheng-Hsien Lu; Hsiu-Ling Chen; Chiun-Chieh Yu; Yueh-Sheng Chen; Yung-Yee Chang; Wei-Che Lin
Journal:  J Clin Med       Date:  2020-01-16       Impact factor: 4.241

Review 10.  Antioxidant Therapeutics in Parkinson's Disease: Current Challenges and Opportunities.

Authors:  Ana Patricia Duarte-Jurado; Yareth Gopar-Cuevas; Odila Saucedo-Cardenas; Maria de Jesus Loera-Arias; Roberto Montes-de-Oca-Luna; Aracely Garcia-Garcia; Humberto Rodriguez-Rocha
Journal:  Antioxidants (Basel)       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.